CLINICAL_TRIALS
trial_result
· 2016-04-26
Clinical Trial Update: A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. [Phase 3]
Summary
Phase 3 trial results for subcutaneous Mircera in the treatment of anemia in dialysis patients have been posted by Hoffmann-La Roche.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-04-26